Zacks Research Estimates Exelon’s Q1 Earnings (NASDAQ:EXC)

Exelon Co. (NASDAQ:EXCFree Report) – Zacks Research lowered their Q1 2025 earnings estimates for shares of Exelon in a note issued to investors on Tuesday, October 29th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $0.71 for the quarter, down from their previous estimate of $0.75. The consensus estimate for Exelon’s current full-year earnings is $2.44 per share. Zacks Research also issued estimates for Exelon’s Q2 2026 earnings at $0.55 EPS.

EXC has been the subject of several other reports. Barclays raised their price target on shares of Exelon from $41.00 to $44.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 15th. UBS Group raised their target price on shares of Exelon from $40.00 to $43.00 and gave the company a “neutral” rating in a research note on Friday, September 20th. Wells Fargo & Company upped their price objective on shares of Exelon from $40.00 to $42.00 and gave the company an “equal weight” rating in a report on Friday, August 2nd. Morgan Stanley upped their price objective on shares of Exelon from $42.00 to $45.00 and gave the company an “equal weight” rating in a report on Wednesday, September 25th. Finally, Scotiabank boosted their target price on shares of Exelon from $37.00 to $40.00 and gave the company a “sector perform” rating in a research report on Tuesday, August 20th. Eleven investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Exelon currently has an average rating of “Hold” and an average price target of $41.33.

View Our Latest Report on Exelon

Exelon Price Performance

Shares of EXC opened at $39.30 on Thursday. The stock has a market capitalization of $39.32 billion, a P/E ratio of 16.17, a P/E/G ratio of 2.90 and a beta of 0.53. Exelon has a twelve month low of $33.35 and a twelve month high of $41.48. The company has a 50 day moving average of $39.65 and a 200-day moving average of $37.70. The company has a quick ratio of 0.93, a current ratio of 1.03 and a debt-to-equity ratio of 1.66.

Exelon (NASDAQ:EXCGet Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $0.71 earnings per share for the quarter, topping the consensus estimate of $0.67 by $0.04. The company had revenue of $6.15 billion during the quarter, compared to analysts’ expectations of $5.85 billion. Exelon had a net margin of 10.65% and a return on equity of 9.40%. The business’s quarterly revenue was up 2.9% on a year-over-year basis. During the same period last year, the business earned $0.67 EPS.

Exelon Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Monday, November 11th will be given a dividend of $0.38 per share. The ex-dividend date is Friday, November 8th. This represents a $1.52 annualized dividend and a yield of 3.87%. Exelon’s dividend payout ratio is 62.55%.

Institutional Investors Weigh In On Exelon

Several institutional investors and hedge funds have recently bought and sold shares of EXC. Crewe Advisors LLC bought a new stake in Exelon during the first quarter worth about $26,000. Versant Capital Management Inc increased its stake in shares of Exelon by 646.2% in the second quarter. Versant Capital Management Inc now owns 776 shares of the company’s stock valued at $27,000 after buying an additional 672 shares during the period. J.Safra Asset Management Corp acquired a new position in shares of Exelon in the second quarter valued at approximately $28,000. American National Bank & Trust increased its stake in shares of Exelon by 178.8% in the third quarter. American National Bank & Trust now owns 697 shares of the company’s stock valued at $28,000 after buying an additional 447 shares during the period. Finally, Abound Wealth Management increased its stake in shares of Exelon by 502.7% in the second quarter. Abound Wealth Management now owns 892 shares of the company’s stock valued at $31,000 after buying an additional 744 shares during the period. Institutional investors own 80.92% of the company’s stock.

About Exelon

(Get Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

Featured Articles

Earnings History and Estimates for Exelon (NASDAQ:EXC)

Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.